NCT05871008Active, not recruiting
Integrated Actionable Aging Assessment for Cancer Patients Pilot
Source: ClinicalTrials.gov · Last updated 3 Nov 2026
Brief summary (registry, in English)
Aging is the greatest risk factor for cancer incidence and mortality. Geriatric screening is recommended to help with treatment discussions, inform intensity of treatment, and identify supportive care needs. Despite a strong evidence base, geriatric assessments are not implemented routinely in oncologic clinics. Similarly, important information on social determinants of health, mental health, and health behaviors are inconsistently assessed, and almost never in an integrated fashion. In an effort to support clinicians delivering the recommended goal-concordant care, the investigators will integrate assessment of geriatric issues, health behaviors, mental health, and social determinants of health into an efficient, actionable contextual assessment system for older cancer patients called Integrated Aging Assessment for Action for Cancer Patients (IA3-CP). The investigators will use D\&I strategies including co-creation engagement approaches and form-function methods to develop workflow processes that feasibly integrate the IA3-CP into usual initial assessment with the oncology team. Our objective is to develop and conduct a randomized pilot of the IA3-CP system and hypothesize that our results will show it can be implemented consistently, acted on, improve quality of care, and enhance patient-provider interactions.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- First submitted
- 24 Apr 2023
- Start date
- 1 Mar 2024
- Primary completion date
- 6 Aug 2024
- Lead sponsor
- University of Colorado, Denver
- Diseases
- Acute lymphoblastic leukaemia, Prostate cancer, Hodgkin lymphoma, Kidney cancer, Bladder cancer, Multiple myeloma, Acute myeloid leukemia
- NCT number
- NCT05871008
What you commit to
- Study type: Interventional
- Planned participants: 35
- From 1 Mar 2024 to the primary completion date, 6 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- age \< 65
Other
- primary language other than English or Spanish
Who the study is looking for
- Age \> /= 65
- Patient must agree to participate in all study-related activities
- English or Spanish speaking
- Attending initial visit to oncology
Age in the registry: 65 years to 111 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Colorado Hospital Coordinator of this site? Confirm its status | Aurora | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.